Skip to main content

Peer Review reports

From: Is it possible to reduce the rate of vertical transmission and improve perinatal outcomes by inclusion of remdesivir in treatment regimen of pregnant women with COVID–19?

Original Submission
4 Mar 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
27 Mar 2022 Reviewed Reviewer Report
22 May 2022 Reviewed Reviewer Report
12 Sep 2022 Author responded Author comments - Shahla Chaichian
Resubmission - Version 5
12 Sep 2022 Submitted Manuscript version 5
19 Sep 2022 Author responded Author comments - Shahla Chaichian
Resubmission - Version 6
19 Sep 2022 Submitted Manuscript version 6
20 Sep 2022 Author responded Author comments - Shahla Chaichian
Resubmission - Version 7
20 Sep 2022 Submitted Manuscript version 7
17 Oct 2022 Reviewed Reviewer Report
3 Nov 2022 Reviewed Reviewer Report
27 Nov 2022 Author responded Author comments - Shahla Chaichian
Resubmission - Version 8
27 Nov 2022 Submitted Manuscript version 8
1 Dec 2022 Author responded Author comments - Shahla Chaichian
Resubmission - Version 9
1 Dec 2022 Submitted Manuscript version 9
Publishing
24 Jan 2023 Editorially accepted
13 Feb 2023 Article published 10.1186/s12884-023-05405-y

You can find further information about peer review here.

Back to article page